<DOC>
	<DOCNO>NCT00168662</DOCNO>
	<brief_summary>The general objective propose research work : A1 ) reduce childhood mortality develop country well control measles infection find best immunization strategy , A2 ) investigate hypothesis standard titre measles immunization associate non target beneficial effect childhood morbidity mortality develop country . The measurable , specific objective present proposal : B1 ) examine whether two-dose strategy measles immunization 6 9 month age reduce measles incidence 50 % good coverage improved seroconversion , B2 ) examine whether two-dose strategy measles immunization 6 9 month age reduce childhood mortality 20 % good coverage , good protection measles non target beneficial effect , B3 ) determine magnitude duration non-measles related change morbidity pattern standard titre measles immunization , particular test whether measles immunization associate 15 % reduction risk diarrhoea , B4 ) determine non-measles related immunological change among recipient measles vaccine order establish possible pathway non target effect standard titre measles immunization .</brief_summary>
	<brief_title>Non-Specific Effects Standard Titre Measles Vaccination</brief_title>
	<detailed_description>Background . Measles major killer among vaccine preventable disease estimate one million deaths/year develop country . Though good vaccine exists , current immunization strategy one dose 9 month far optimal ; many child get measles age immunization , coverage low immunization wait 9 month age , protective efficacy insufficient current vaccine give 9 month age . There therefore need alternative immunization strategy new vaccine . Evaluations vaccine usually base disease specific perspective ; i.e . evaluation specific immunity , protective efficacy specific disease , complication mortality . However , research Guinea-Bissau , Senegal Bangladesh indicate measles immunization measles infection may non-specific beneficial effect . The present protocol attempt assess magnitude possible mechanism non target beneficial effect measles immunization measles infection well attempt assess practical implication hypothesis non-specific beneficial effect . Approach methodology . We test two dose measles immunization strategy 6 9 month compare currently recommend strategy one dose 9 month . The child randomize receive measles immunization 6 9 month age inactivate polio 6 month measles 9 month age . The non target effect measles immunization mortality morbidity best study within randomized trial compare immunize unimmunized child . In order study impact non-measles related morbidity , child recruit immunization trial include weekly morbidity surveillance diarrhoea , respiratory infection malaria important disease complex childhood mortality Guinea-Bissau . Possible immunological difference measles immunize unimmunized child examine measurement T-lymphocyte level , neopterin , beta2-microglobulin , delayed hypersensitivity ( Multitest ) , allergic reaction ( skin prick test ) , antibody response antigen ( tetanus ) thymus growth ( sonography ) . Functional difference test response second vaccine antigen ( HBV ) 7½ 9 month age one group receive measles vaccine .</detailed_description>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants 6 month age register Bandim Health Project registration system currently live Bandim Health Project area : Bandim I , Bandim II , Belem Mindará Severe illness require hospitalisation</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>8 Months</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Non-specific effect vaccine</keyword>
	<keyword>Infant mortality</keyword>
	<keyword>Child mortality</keyword>
	<keyword>Mortality</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Measles vaccine</keyword>
	<keyword>Measles</keyword>
	<keyword>Immunisation</keyword>
	<keyword>Low income country</keyword>
	<keyword>Guinea-Bissau</keyword>
	<keyword>Bandim Health Project</keyword>
	<keyword>Immunology</keyword>
</DOC>